课题基金 / 基金详情

SANDIMMUNE IN STABLE RENAL TRANSPLANT PATIENTS WHO ABSORB CYCLOSPORINE POORLY

SANDIMMUNE IN STABLE RENAL TRANSPLANT PATIENTS WHO ABSORB CYCLOSPORINE POORLY
SANDIMUNE 用于环孢素吸收不良的稳定肾移植患者
批准号：
6113530
负责人：
ALAN B LEICHTMAN
金额：
$2.14万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/6113530
关键词：
clinical research cyclosporines dosage forms drug screening /evaluation gastrointestinal drug absorption human subject human therapy evaluation immunosuppression kidney transplantation malabsorption oral administration pharmacokinetics

项目摘要

项目成果

ALAN B LEICHTMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study is being performed to determine if Sandimmune oral solution and Sandimmune soft gelatin capsules are bioequivalent in stable renal transplant recipients who absorb cyclosporine poorly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIROLIMUS AZATHIOPRINE WITH IMMUNOSUPPRESSIVE THERAPY IN ALLOGRAFT RECIPIENTS
SIROLIMUS AZATHIOPRINE WITH IMMUNOSUPPRESSIVE THERAPY IN ALLOGRAFT RECIPIENTS
ACUTE RENAL GRAFT REJECTION W/ BMY-42215-1 (15-DEOXYSPERGUALIN TRIHYDROCHLORIDE)
SIROLIMUS AZATHIOPRINE WITH IMMUNOSUPPRESSIVE THERAPY IN ALLOGRAFT RECIPIENTS
海外基金